I am a co-founder, owner and CEO of The Burlington HC Research Group, Inc. (BHCRG), which owns a new family of drugs, BRG Therapeutics. Based on our pre-clinical tissue culture studies, 2 BRG drugs are highly effective against 15 human cancer cell lines.